Research Peptides in Bangkok

10mg/vial · Triple GIP/GLP-1/Glucagon Agonist

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated up to 24.2% mean body weight reduction at 48 weeks — the highest efficacy reported among investigational peptides.The glucagon receptor component adds direct hepatic fat oxidation, making it uniquely potent for metabolic research.

20mg/vial · Triple GIP/GLP-1/Glucagon Agonist — Extended Protocol

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated up to 24.2% mean body weight reduction at 48 weeks — the highest efficacy reported among investigational peptides.The glucagon receptor component adds direct hepatic fat oxidation, making it uniquely potent for metabolic research.

10mg/vial · Dual GIP/GLP-1 Agonist

Tirzepatide is a dual GIP and GLP-1 receptor agonist that demonstrated up to 22.5% weight reduction in the SURMOUNT clinical trials. Marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, it combines complementary metabolic pathways for superior efficacy over single-receptor agonists — a benchmark peptide for obesity and metabolic research.

10mg/vial · GLP-1 Agonist

Semaglutide is a GLP-1 receptor agonist with the most extensive clinical track record in its class. The STEP trials demonstrated 15–17% mean body weight reduction at 68 weeks across thousands of participants. Marketed as Ozempic for type 2 diabetes and Wegovy for weight management, it is the gold-standard reference peptide for GLP-1 receptor research.

10mg/vial · Mitochondria-Derived Metabolic Peptide

MOTS-C is a mitochondria-derived peptide encoded by the mitochondrial genome. Research has investigated its role in metabolic regulation, insulin sensitivity, and energy homeostasis. Lotus Labs supplies MOTS-C at >98% purity for laboratory research only.

10mg/vial · GHRH Analogue for Visceral Fat Research

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Research has examined its effects on visceral adipose tissue reduction and GH-axis stimulation. Lotus Labs supplies Tesamorelin at >98% purity for laboratory research only.